NL-OMON27024招募中不适用
99mTc-Senti-Scint vs. ICG-99mTc-nanocolloid for sentinel node biopsy of melanoma of the head and neck, trunk or of and extremity
KI-AV0 个研究点目标入组 38 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 38
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients >18 years;
- •Patients with a primary melanoma of the trunk , of an extremity or in the head and neck region;
排除标准
- •Patients with known allergy to patent blue;
- •Patients who are pregnant or nursing mothers;
研究者
相似试验
招募中
不适用
ICG-99mTc-nanocolloid vs. 99mTc-nanocolloid en een intraoperatieve injectie van ICG voor de schildwachtklierprocedure van prostaat kanker.prostate cancer, sentinel lymph nodeNL-OMON28336etherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI/AVL)138
招募中
不适用
Injection of 99mTc-nanocolloid and ICG to identify, retrieve and qualify tumor draining lymph nodes in early-stage lungcancerlung tumorNL-OMON51465Radboud Universitair Medisch Centrum60
招募中
不适用
ew tracer compared with traditional radioactive tracer for sentinel lymph node biopsy in breast cancer: The FLUORO trialSurgery - Surgical techniquesCancer - Breastbreast cancerACTRN12621001033831Chris O'Brien Lifehouse290
已完成
不适用
Validation of ICG-99mTc-nanoscan as Hybrid Tracer for Sentinel Node BiopsyPenile CancerMelanomaOral CancerNCT06666634The Netherlands Cancer Institute29
尚未招募
3 期
Validation of ICG-99mTc-nanoscan as hybrid tracer for sentinel node biopsyNL-OMON51806Antoni van Leeuwenhoek Ziekenhuis29